ghk-cu tolerance downregulation desensitization long-term use effectiveness Peptide: Clinical Evidence & Injectable Protocols Does GHK-Cu Really Work? 40
Description
c-Met is a receptor tyrosine kinase that is overexpressed in numerous tumors
[DOI] [Google Scholar] Ghosh S
Start with a low concentration (0.5-1%), apply every third day initially, and increase frequency gradually
Mean new or enlarging T2 lesions at week 72 were 0.20 in the every-6-weeks group and 0.05 in the every-4-weeks group, with a mean lesion ratio of 4.24
